Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home
January 2011
NIOSH Docket Number 215

NIOSH Guideline: Application of Digital Radiography for the Detection and Classification of Pneumoconiosis

Monitoring the health of individuals involved in dusty work is intended to provide assurance to the worker that ongoing exposure controls are adequate. Recognition of minor health abnormalities serves as an early warning to both workers and managers when there is need for more effective measures to prevent work-related impairment and disability. Since 1970, NIOSH and other organizations have successfully applied traditional film screen chest radiography, interpreted using the ILO International Classification of Radiographs of Pneumoconiosis, toward these objectives. Imaging of interstitial lung diseases such as the pneumoconiosis represents one of the most difficult challenges in diagnostic radiology, and comprehensive attention to technological, methodological, and human factors is required to assure that the image quality and interpretation are satisfactory for achieving early disease detection. This NIOSH Guideline is based upon accepted contemporary professional recommendations, and provides technical and operational guidance for radiographic facilities and physician readers who obtain digital chest radiographs for the evaluation of pneumoconiosis. The intent is to assure that the recognition of pneumoconiosis using digitally-acquired chest radiographs is at least as safe and effective as traditional film screen radiography. The Guideline should not be considered a mandate for medical practice; however participating practitioners and facilities who deviate from the specifications should have a sound medical rationale for alternative approaches.


NIOSH is Seeking Comment from Stakeholders on the following:


Public Comment Period

Interested persons or organizations are invited to participate in this process by submitting written views, recommendations, and data. Written comments on the document will be accepted through March 18, 2011 in accordance with the instructions below. All material submitted to NIOSH should reference Docket Number NIOSH-215. All electronic comments should be formatted as Microsoft Word and make reference to docket number NIOSH-215.

Comments will be accepted until 5:00 p.m. EDT on March 18, 2011

To submit comments, please use one of these options:

  • Send NIOSH comments using this online form

  • Send comments by email.

  • Fax comments to the NIOSH Docket Office: 513-533-8285

  • Send by Mail to:
    NIOSH Mailstop: C-34
    Robert A. Taft Lab.
    4676 Columbia Parkway
    Cincinnati, Ohio 45226

All information received in response to this notice will be available for public examination and copying at:
NIOSH Docket Office
4676 Columbia Parkway, Room 111
Cincinnati, Ohio 45226.

A complete electronic docket containing all comments submitted will be available on the NIOSH docket home page, and comments will be available in writing by request. NIOSH includes all comments received without change in the docket, including any personal information provided.

Contact person for information

Michael Attfield
Surveillance Branch, NIOSH, MS900.2
1095 Willowdale Road
Morgantown, WV, 26505
304-285-5737

 

 
Contact Us:
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - cdcinfo@cdc.gov